Clinical Trials Logo

Clinical Trial Summary

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.


Clinical Trial Description

Borderline personality disorder defined as "a pattern of instability in interpersonal relationships, self-image and affects, and impulsiveness marked" concerns 4-6% of the general population. This is the emotional trouble the most associated with the occurence of suicide attempts (85% of these patients make multiple suicide attempts) and death by suicide (10% of these patients). This is a major public health problem. A large number of patients with borderline personality disorder are not informed of their diagnosis. The main reasons are : the non-recognition of this disorder by health professionals, the belief that borderline personality disorder is a overly stigmatizing diagnosis , or preference to diagnose another disorder - that professionals think respond better to treatments and therefore be of a better prognosis. Patients with borderline personality disorder often think themselves as "bad people" or the only people suffering from these symptoms. Thus, the ignorance of borderline personality disorder by patients leads to a basis of their altered sense of identity, perceived as defective or isolated. This generate a strong internalized stigma. Many people diagnosed with borderline personality disorder receive no information about this disorder while psychoeducation has shown its effectiveness in severe psychiatric disorders, including the disorder of borderline personality, by reducing the negative repercussions psychiatric pathology. Moreover, the education of patients suffering from self-stigma makes it possible to in the face of negative beliefs around the disease and the acquisition of knowledge about the disorder and how to deal with it reduces self-stigma in bipolar patients. However, the propensity to feel shame - the stigmatization of oneself as worthless - is strongest in borderline personality disorder compared to all psychiatric disorders and most associated with the occurence of suicidal behaviors. In recommendations with good clinical practice, the investigator propose within the sector a day of education on borderline personality disorder including a transmission of current scientific knowledge on the illness, a dimensional understanding of the disorder, and the dis-identification of self to the symptoms of borderline personality disorder. The investigator hypothesize that this day of psychoeducation makes it possible to decrease self-stigma, which could be a mediator in reducing negative repercussions of borderline pathology. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05428462
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date January 1, 2021
Completion date September 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Active, not recruiting NCT04587518 - Five Factor Model Treatment for Borderline Personality Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT03677037 - The Short-Term MBT Project Phase 3
Not yet recruiting NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences
Completed NCT02518906 - Evaluation of AIT Study N/A
Completed NCT02068326 - MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Completed NCT02108990 - Acetaminophen and Social Processes Phase 2
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Completed NCT02988037 - Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study N/A
Completed NCT01635556 - Evaluation of a Modified Dialectical Behavior Therapy Program N/A
Not yet recruiting NCT01683136 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder N/A
Completed NCT02397031 - Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder N/A
Terminated NCT01103180 - Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Phase 2
Terminated NCT01212588 - Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Phase 2
Terminated NCT00539188 - N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Phase 2
Recruiting NCT05398627 - Neurofeedback for Borderline Personality Disorder N/A
Recruiting NCT03994510 - SHame prOpensity in bOrderline Personality Disorder N/A
Recruiting NCT06005129 - Personality Change Study for Borderline Personality Disorder N/A